145 related articles for article (PubMed ID: 2490443)
1. [Canine leishmaniasis in Spain: data for the clinician].
Ferrer L
Enferm Infecc Microbiol Clin; 1989; 7(6):293-5. PubMed ID: 2490443
[No Abstract] [Full Text] [Related]
2. Clinical and parasitological evaluation of dogs naturally infected by Leishmania (Leishmania) chagasi submitted to treatment with meglumine antimoniate.
Ikeda-Garcia FA; Lopes RS; Marques FJ; de Lima VM; Morinishi CK; Bonello FL; Zanette MF; Perri SH; Feitosa MM
Vet Parasitol; 2007 Feb; 143(3-4):254-9. PubMed ID: 16996214
[TBL] [Abstract][Full Text] [Related]
3. [Leishmaniasis: hospital and population-based incidence, and asymptomatic infection. A disease that is still with us].
Bellido-Blasco JB; Arnedo-Pena A; Romeo-García MA; Herrero-Carot C
Enferm Infecc Microbiol Clin; 2009 Feb; 27(2):136-7. PubMed ID: 19254647
[No Abstract] [Full Text] [Related]
4. Visceral leishmaniasis and disseminated intravascular coagulation in a dog.
Font A; Gines C; Closa JM; Mascort J
J Am Vet Med Assoc; 1994 Apr; 204(7):1043-4. PubMed ID: 8045804
[TBL] [Abstract][Full Text] [Related]
5. [Meeting "Visceral leishmaniasis in Maghreb", 2-4 April 2015 in Tunis. Recommendations].
Aoun K; Laamrani El Idrissi A; Harrat Z; Marty P
Bull Soc Pathol Exot; 2015 Aug; 108(3):229-30. PubMed ID: 26002086
[No Abstract] [Full Text] [Related]
6. Canine visceral leishmaniasis: comparison of in vitro leishmanicidal activity of marbofloxacin, meglumine antimoniate and sodium stibogluconate.
Vouldoukis I; Rougier S; Dugas B; Pino P; Mazier D; Woehrlé F
Vet Parasitol; 2006 Jan; 135(2):137-46. PubMed ID: 16242844
[TBL] [Abstract][Full Text] [Related]
7. Use of meglumine antimoniate in canine leishmaniasis.
Lamothe J
Vet Rec; 2004 Mar; 154(12):378. PubMed ID: 15074332
[No Abstract] [Full Text] [Related]
8. First report of the use of meglumine antimoniate for treatment of canine leishmaniasis in a pregnant dog.
Spada E; Proverbio D; Groppetti D; Perego R; Grieco V; Ferro E
J Am Anim Hosp Assoc; 2011; 47(1):67-71. PubMed ID: 21164165
[TBL] [Abstract][Full Text] [Related]
9. Canine visceral leishmaniasis: Diagnosis and management of the reservoir living among us.
Travi BL; Cordeiro-da-Silva A; Dantas-Torres F; Miró G
PLoS Negl Trop Dis; 2018 Jan; 12(1):e0006082. PubMed ID: 29324838
[TBL] [Abstract][Full Text] [Related]
10. Pancreatitis associated with N-methyl-glucamine therapy in a dog with leishmaniasis.
Aste G; Di Tommaso M; Steiner JM; Williams DA; Boari A
Vet Res Commun; 2005 Aug; 29 Suppl 2():269-72. PubMed ID: 16244972
[No Abstract] [Full Text] [Related]
11. Evolution of serum albumin/globulin ratio after antimonial therapy in canine leishmaniasis.
Amusategui I; Sainz A; Tesouro MA
Ann N Y Acad Sci; 1998 Jun; 849():447-9. PubMed ID: 9668510
[No Abstract] [Full Text] [Related]
12. Clinical follow-up examination after treatment of canine leishmaniasis.
Moritz A; Steuber S; Greiner M
Tokai J Exp Clin Med; 1998 Dec; 23(6):279-83. PubMed ID: 10622623
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of renal and hepatic functions in dogs naturally infected by visceral leishmaniasis submitted to treatment with meglumine antimoniate.
Ikeda-Garcia FA; Lopes RS; Ciarlini PC; Marques FJ; Lima VM; Perri SH; Feitosa MM
Res Vet Sci; 2007 Aug; 83(1):105-8. PubMed ID: 17150234
[TBL] [Abstract][Full Text] [Related]
14. The effects of prednisone on haemostasis in leishmaniotic dogs treated with meglumine antimoniate and allopurinol.
Cortese L; Pelagalli A; Piantedosi D; Mastellone V; Di Loria A; Lombardi P; Ciaramella P; Avallone L
Vet J; 2008 Sep; 177(3):405-10. PubMed ID: 17629526
[TBL] [Abstract][Full Text] [Related]
15. Studies on canine leishmaniasis control. 2. Effectiveness of control measures against canine leishmaniasis in the Isle of Elba, Italy.
Gradoni L; Gramiccia M; Mancianti F; Pieri S
Trans R Soc Trop Med Hyg; 1988; 82(4):568-71. PubMed ID: 3256109
[TBL] [Abstract][Full Text] [Related]
16. Our experiences in visceral leishmaniasis therapy.
Titone L; Scarlata F; Cascio A; Giordano S; Mancuso G
J Chemother; 1989 Jul; 1(4 Suppl):960-1. PubMed ID: 16312722
[No Abstract] [Full Text] [Related]
17. Comparative efficacy of meglumine antimoniate and aminosidine sulphate, alone or in combination, in canine leishmaniasis.
Oliva G; Gradoni L; Cortese L; Orsini S; Ciaramella P; Scalone A; de Luna R; Persechino A
Ann Trop Med Parasitol; 1998 Mar; 92(2):165-71. PubMed ID: 9625912
[TBL] [Abstract][Full Text] [Related]
18. Leishmania infantum infection rates in Phlebotomus perniciosus fed on naturally infected dogs under antimonial treatment.
Gradoni L; Maroli M; Gramiccia M; Mancianti F
Med Vet Entomol; 1987 Oct; 1(4):339-42. PubMed ID: 2979550
[TBL] [Abstract][Full Text] [Related]
19. Decreased sensitivity to meglumine antimoniate (Glucantime) of Leishmania infantum isolated from dogs after several courses of drug treatment.
Gramiccia M; Gradoni L; Orsini S
Ann Trop Med Parasitol; 1992 Dec; 86(6):613-20. PubMed ID: 1304703
[TBL] [Abstract][Full Text] [Related]
20. Antileishmanial activity of liposome-encapsulated meglumine antimonate in the dog.
Chapman WL; Hanson WL; Alving CR; Hendricks LD
Am J Vet Res; 1984 May; 45(5):1028-30. PubMed ID: 6732008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
